Related Experiment Video

Updated: Jun 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

MicroRNA-26a is a novel regulator of vascular smooth muscle cell function

Nicholas J Leeper1, Azad Raiesdana, Yoko Kojima

  • 1Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA. nleeper@stanford.edu

Journal of Cellular Physiology
|September 22, 2010
PubMed

Insights

MicroRNA-26a promotes vascular smooth muscle cell (SMC) proliferation and inhibits differentiation. This microRNA is downregulated in abdominal aortic aneurysm (AAA) disease, suggesting it is a potential therapeutic target.

Area of Science:

  • Vascular Biology
  • Epigenetics
  • Molecular Medicine

Background:

  • Aberrant smooth muscle cell (SMC) plasticity is linked to vascular disorders like atherosclerosis and abdominal aortic aneurysm (AAA).
  • MicroRNAs (miRNAs) are known epigenetic regulators of SMCs, but their full role in vascular SMC phenotype remains to be elucidated.
  • Identifying novel miRNAs involved in SMC plasticity is crucial for understanding and treating vascular diseases.

Purpose of the Study:

  • To investigate the role of specific microRNAs in regulating vascular SMC phenotype and plasticity.
  • To identify novel miRNAs involved in the pathogenesis of abdominal aortic aneurysm (AAA).
  • To explore the mechanistic link between miRNA-26a and TGF-β signaling in SMCs.

Main Methods:

  • Microarray analysis of miRNAs in human aortic SMCs undergoing phenotypic switching.
  • Functional studies involving inhibition and overexpression of miRNA-26a in human SMCs.
  • Dual-luciferase reporter assays to assess SMAD signaling pathway activity.
  • Analysis of miRNA-26a expression in mouse models of AAA.

Main Results:

  • Microarray identified 31 significantly regulated miRNAs, with miRNA-26a selected for further study.
  • Inhibition of miRNA-26a accelerated SMC differentiation and apoptosis while inhibiting proliferation and migration.
  • Overexpression of miRNA-26a blunted SMC differentiation and affected SMAD signaling.
  • miRNA-26a was significantly downregulated in mouse models of AAA, correlating with increased SMC synthetic phenotype.

Conclusions:

  • miRNA-26a promotes vascular SMC proliferation and inhibits differentiation and apoptosis.
  • miRNA-26a modulates TGF-β pathway signaling, specifically influencing SMAD activity.
  • Downregulation of miRNA-26a in AAA disease suggests its role as a key regulator of SMC biology and a potential therapeutic target.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...